[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://global.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1329651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Joseph Trizzino B.S., M.B.A.", "age": 64, "title": "President & COO", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 670550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 716175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Casey", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 137357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 56, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.43, "open": 5.46, "dayLow": 5.3519, "dayHigh": 5.93, "regularMarketPreviousClose": 5.43, "regularMarketOpen": 5.46, "regularMarketDayLow": 5.3519, "regularMarketDayHigh": 5.93, "payoutRatio": 0.0, "beta": 3.144, "forwardPE": -36.625, "volume": 6634332, "regularMarketVolume": 6634332, "averageVolume": 4688000, "averageVolume10days": 8497780, "averageDailyVolume10Day": 8497780, "bid": 5.8, "ask": 5.91, "bidSize": 5, "askSize": 33, "marketCap": 942545856, "fiftyTwoWeekLow": 3.81, "fiftyTwoWeekHigh": 23.86, "priceToSalesTrailing12Months": 1.3817039, "fiftyDayAverage": 7.5618, "twoHundredDayAverage": 10.1633, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 344020800, "profitMargins": -0.27486, "floatShares": 135577182, "sharesOutstanding": 160844000, "sharesShort": 37551429, "sharesShortPriorMonth": 35447513, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.2335, "heldPercentInsiders": 0.08801, "heldPercentInstitutions": 0.60207003, "shortRatio": 7.71, "shortPercentOfFloat": 0.2909, "impliedSharesOutstanding": 160844000, "bookValue": -3.889, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -187499008, "trailingEps": -1.23, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.504, "enterpriseToEbitda": -1.875, "52WeekChange": 0.42233014, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 5.86, "targetHighPrice": 25.0, "targetLowPrice": 9.0, "targetMeanPrice": 16.42857, "targetMedianPrice": 19.0, "recommendationMean": 2.14286, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 923118016, "totalCashPerShare": 5.739, "ebitda": -183435008, "totalDebt": 263471008, "quickRatio": 0.893, "currentRatio": 0.978, "totalRevenue": 682161984, "revenuePerShare": 4.482, "returnOnAssets": -0.086339995, "grossProfits": 112522000, "freeCashflow": -175641744, "operatingCashflow": -87263000, "revenueGrowth": -0.697, "grossMargins": 0.16495001, "ebitdaMargins": -0.2689, "operatingMargins": -1.4208901, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 7.918975, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "marketState": "CLOSED", "regularMarketPrice": 5.86, "corporateActions": [], "postMarketTime": 1744415978, "regularMarketTime": 1744401601, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": -0.172361, "postMarketPrice": 5.8499, "postMarketChange": -0.0101004, "regularMarketChange": 0.4300003, "regularMarketDayRange": "5.3519 - 5.93", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4688000, "fiftyTwoWeekLowChange": 2.0500002, "fiftyTwoWeekLowChangePercent": 0.5380578, "fiftyTwoWeekRange": "3.81 - 23.86", "fiftyTwoWeekHighChange": -18.0, "fiftyTwoWeekHighChangePercent": -0.7544007, "fiftyTwoWeekChangePercent": 42.233013, "dividendDate": 1557446400, "earningsTimestamp": 1740663000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.23, "epsForward": -0.16, "epsCurrentYear": 0.106, "priceEpsCurrentYear": 55.28302, "fiftyDayAverageChange": -1.7017999, "fiftyDayAverageChangePercent": -0.22505222, "twoHundredDayAverageChange": -4.3032994, "twoHundredDayAverageChangePercent": -0.42341557, "priceToBook": -1.5068141, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "cryptoTradeable": false, "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]